Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Health behaviours reported by adults with congenital heart disease across 15 countries.

Holbein CE, Peugh J, Veldtman GR, Apers S, Luyckx K, Kovacs AH, Thomet C, Budts W, Enomoto J, Sluman MA, Lu CW, Jackson JL, Khairy P, Cook SC, Chidambarathanu S, Alday L, Eriksen K, Dellborg M, Berghammer M, Johansson B, Mackie AS, Menahem S, Caruana M, Soufi A, Fernandes SM, White K, Callus E, Kutty S, Moons P; APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD).

Eur J Prev Cardiol. 2019 Sep 17:2047487319876231. doi: 10.1177/2047487319876231. [Epub ahead of print]

PMID:
31529991
2.

Learning strategies among adult CHD fellows.

Bokma JP, Daily JA, Kovacs AH, Oechslin EN, Baumgartner H, Khairy P, Mulder BJM, Veldtman GR.

Cardiol Young. 2019 Nov;29(11):1356-1360. doi: 10.1017/S1047951119002063. Epub 2019 Sep 10.

PMID:
31502529
3.

Relation of Magnetic Resonance Elastography to Fontan Failure and Portal Hypertension.

Alsaied T, Possner M, Lubert AM, Trout AT, Szugye C, Palermo JJ, Lorts A, Goldstein BH, Veldtman GR, Anwar N, Dillman JR.

Am J Cardiol. 2019 Nov 1;124(9):1454-1459. doi: 10.1016/j.amjcard.2019.07.052. Epub 2019 Aug 7.

PMID:
31474329
4.

Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe.

Yang H, Veldtman GR, Bouma BJ, Budts W, Niwa K, Meijboom F, Scognamiglio G, Egbe AC, Schwerzmann M, Broberg C, Morissens M, Buber J, Tsai S, Polyzois I, Post MC, Greutmann M, Van Dijk A, Mulder BJ, Aboulhosn J.

Open Heart. 2019 Jun 3;6(1):e000985. doi: 10.1136/openhrt-2018-000985. eCollection 2019.

5.

Perceived Health Mediates Effects of Physical Activity on Quality of Life in Patients With a Fontan Circulation.

Holbein CE, Veldtman GR, Moons P, Kovacs AH, Luyckx K, Apers S, Chidambarathanu S, Soufi A, Eriksen K, Jackson JL, Enomoto J, Fernandes SM, Johansson B, Alday L, Dellborg M, Berghammer M, Menahem S, Caruana M, Kutty S, Mackie AS, Thomet C, Budts W, White K, Sluman MA, Callus E, Cook SC, Khairy P, Cedars A; APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD).

Am J Cardiol. 2019 Jul 1;124(1):144-150. doi: 10.1016/j.amjcard.2019.03.039. Epub 2019 Apr 10.

PMID:
31030969
6.

Optimum age for performing Fontan operation in patients with univentricular heart.

Akintoye E, Veldtman GR, Miranda WR, Connolly HM, Egbe AC.

Congenit Heart Dis. 2019 Mar;14(2):138-139. doi: 10.1111/chd.12690.

PMID:
30945806
7.

Assessment of liver T1 mapping in fontan patients and its correlation with magnetic resonance elastography-derived liver stiffness.

Ramachandran P, Serai SD, Veldtman GR, Lang SM, Mazur W, Trout AT, Dillman JR, Fleck RJ, Taylor MD, Alsaied T, Moore RA.

Abdom Radiol (NY). 2019 Jul;44(7):2403-2408. doi: 10.1007/s00261-019-01990-9.

PMID:
30903232
8.

Focal liver lesions following Fontan palliation of single ventricle physiology: A radiology-pathology case series.

Engelhardt EM, Trout AT, Sheridan RM, Veldtman GR, Dillman JR.

Congenit Heart Dis. 2019 May;14(3):380-388. doi: 10.1111/chd.12730. Epub 2018 Dec 20.

PMID:
30569564
9.

National trends in Fontan operation and in-hospital outcomes in the USA.

Akintoye E, Miranda WR, Veldtman GR, Connolly HM, Egbe AC.

Heart. 2019 May;105(9):708-714. doi: 10.1136/heartjnl-2018-313680. Epub 2018 Oct 30.

PMID:
30377261
10.

Hepatocellular Carcinoma After Fontan Operation.

Egbe AC, Poterucha JT, Warnes CA, Connolly HM, Baskar S, Ginde S, Clift P, Kogon B, Book WM, Walker N, Wagenaar L, Moe T, Oechslin E, Kay WA, Norris M, Gordon-Walker T, Dillman JR, Trout A, Anwar N, Hoskoppal A, Veldtman GR.

Circulation. 2018 Aug 14;138(7):746-748. doi: 10.1161/CIRCULATIONAHA.117.032717. No abstract available.

PMID:
30359134
11.

MRI measured liver stiffness does not predict focal liver lesions after the Fontan operation.

Diaz ES, Dillman JR, Veldtman GR, Trout AT.

Pediatr Radiol. 2019 Jan;49(1):99-104. doi: 10.1007/s00247-018-4264-z. Epub 2018 Sep 29.

PMID:
30269160
12.

Echocardiography in adults with congenital heart disease: Combining the best of both worlds.

Tretter JT, Oechslin EN, Veldtman GR.

Int J Cardiol. 2018 Dec 1;272:84-85. doi: 10.1016/j.ijcard.2018.04.008. Epub 2018 Aug 29. No abstract available.

PMID:
30172476
13.

Characteristics of hospital admissions associated with implantable cardioverter defibrillator placement among adults with congenital heart disease.

Baskar S, Veldtman GR, Khoury PR, Opotowsky AR, Cedars AM.

Int J Cardiol. 2018 Oct 15;269:97-103. doi: 10.1016/j.ijcard.2018.07.085. Epub 2018 Jul 24.

PMID:
30060972
14.

Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review.

Udholm S, Aldweib N, Hjortdal VE, Veldtman GR.

Open Heart. 2018 Jul 3;5(1):e000812. doi: 10.1136/openhrt-2018-000812. eCollection 2018.

15.

Consensus recommendations for echocardiography in adults with congenital heart defects from the International Society of Adult Congenital Heart Disease (ISACHD).

Li W, West C, McGhie J, van den Bosch AE, Babu-Narayan SV, Meijboom F, Mongeon FP, Khairy P, Kimball TR, Beauchesne LM, Ammash NM, Veldtman GR, Oechslin E, Gatzoulis MA, Webb G.

Int J Cardiol. 2018 Dec 1;272:77-83. doi: 10.1016/j.ijcard.2018.07.058. Epub 2018 Jul 11. Review.

16.

Pregnancy in Women With a Fontan Circulation: A Systematic Review of the Literature.

Garcia Ropero A, Baskar S, Roos Hesselink JW, Girnius A, Zentner D, Swan L, Ladouceur M, Brown N, Veldtman GR.

Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004575. doi: 10.1161/CIRCOUTCOMES.117.004575.

PMID:
29752389
17.

Bridging the psychological issues of living with the Fontan circulation.

Brida M, Grbcic S, Holbein C, Veldtman GR.

Int J Cardiol. 2018 Jun 1;260:72-73. doi: 10.1016/j.ijcard.2018.02.105. No abstract available.

PMID:
29622457
18.

Mechanism for temporal changes in exercise capacity after Fontan palliation: Role of Doppler echocardiography.

Egbe A, Khan AR, Miranda WR, Ammash NM, Warnes CA, Said SS, Taggart NW, Akintoye E, Veldtman GR, Connolly HM.

Am Heart J. 2018 Feb;196:144-152. doi: 10.1016/j.ahj.2017.10.010. Epub 2017 Oct 22.

PMID:
29421006
19.

Fontan-Associated Liver Disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC.

Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH 3rd, Book W, Gurvitz M, John A, John B, Marelli A, Marino BS, Minich LL, Poterucha JJ, Rand EB, Veldtman GR.

J Am Coll Cardiol. 2017 Dec 26;70(25):3173-3194. doi: 10.1016/j.jacc.2017.10.045. Review.

20.

Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.

Egbe AC, Connolly HM, Miranda WR, Ammash NM, Hagler DJ, Veldtman GR, Borlaug BA.

Circ Heart Fail. 2017 Dec;10(12). pii: e004515. doi: 10.1161/CIRCHEARTFAILURE.117.004515.

21.

Role of Doppler echocardiography for cardiac output assessment in Fontan patients.

Egbe A, Khan AR, Khan SF, Anavekar NS, Said SM, Young PM, Akintoye E, Miranda WR, Al-Otaibi MN, Veldtman GR, Connolly HM.

Am Heart J. 2018 Jan;195:91-98. doi: 10.1016/j.ahj.2017.09.014. Epub 2017 Sep 21.

PMID:
29224651
22.

Histopathological abnormalities in the central arteries and veins of Fontan subjects.

Hays BS, Baker M, Laib A, Tan W, Udholm S, Goldstein BH, Sanders SP, Opotowsky AR, Veldtman GR.

Heart. 2018 Feb;104(4):324-331. doi: 10.1136/heartjnl-2017-311838. Epub 2017 Sep 29.

PMID:
28970278
23.

Cardiovascular adaptation to the Fontan circulation.

Veldtman GR, Opotowsky AR, Wittekind SG, Rychik J, Penny DJ, Fogel M, Marino BS, Gewillig M.

Congenit Heart Dis. 2017 Dec;12(6):699-710. doi: 10.1111/chd.12526. Epub 2017 Aug 10. Review.

PMID:
28795517
24.

Intermediate term thrombotic risk in contemporary total cavo-pulmonary connection for single ventricle circulations.

Faircloth JM, Roe O, Alsaied T, Palumbo JS, Vinks A, Veldtman GR.

J Thromb Thrombolysis. 2017 Oct;44(3):275-280. doi: 10.1007/s11239-017-1530-0.

PMID:
28761995
25.

Genotype-phenotype correlations in Marfan syndrome.

Landis BJ, Veldtman GR, Ware SM.

Heart. 2017 Nov;103(22):1750-1752. doi: 10.1136/heartjnl-2017-311513. Epub 2017 Jun 8. No abstract available.

PMID:
28596305
26.

Predicting long-term mortality after Fontan procedures: A risk score based on 6707 patients from 28 studies.

Alsaied T, Bokma JP, Engel ME, Kuijpers JM, Hanke SP, Zuhlke L, Zhang B, Veldtman GR.

Congenit Heart Dis. 2017 Jul;12(4):393-398. doi: 10.1111/chd.12468. Epub 2017 May 8. Review.

PMID:
28480627
27.

Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.

Faircloth JM, Miner KM, Alsaied T, Nelson N, Ciambarella J, Mizuno T, Palumbo JS, Vinks AA, Veldtman GR.

J Thromb Thrombolysis. 2017 Jul;44(1):38-47. doi: 10.1007/s11239-017-1499-8.

PMID:
28429248
28.

Noninvasive Imaging in Adult Congenital Heart Disease.

Burchill LJ, Huang J, Tretter JT, Khan AM, Crean AM, Veldtman GR, Kaul S, Broberg CS.

Circ Res. 2017 Mar 17;120(6):995-1014. doi: 10.1161/CIRCRESAHA.116.308983. Review.

PMID:
28302744
29.

Corrigendum to 'Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology' [Int. J. Cardiol. 220 (2016) 131-136].

Ertekin E, van Hagen IM, Salam AM, Ruys TP, Johnson MR, Popelova J, Parsonage WA, Ashour Z, Shotan A, Oliver JM, Veldtman GR, Hall R, Roos-Hesselink JW.

Int J Cardiol. 2017 Apr 1;232:348. doi: 10.1016/j.ijcard.2017.01.077. Epub 2017 Jan 27. No abstract available.

30.

Factors associated with long-term mortality after Fontan procedures: a systematic review.

Alsaied T, Bokma JP, Engel ME, Kuijpers JM, Hanke SP, Zuhlke L, Zhang B, Veldtman GR.

Heart. 2017 Jan 15;103(2):104-110. doi: 10.1136/heartjnl-2016-310108. Epub 2016 Nov 9. Review.

PMID:
28057809
31.

Adverse outcome of coarctation stenting in patients with Turner syndrome.

van den Hoven AT, Duijnhouwer AL, Eicken A, Aboulhosn J, de Bruin C, Backeljauw PF, Demulier L, Chessa M, Uebing A, Veldtman GR, Armstrong AK, van den Bosch AE, Witsenburg M, Roos-Hesselink JW.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):280-287. doi: 10.1002/ccd.26728. Epub 2016 Sep 15. Review.

PMID:
27629084
32.

Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology.

Ertekin E, van Hagen IM, Salam AM, Ruys TP, Johnson MR, Popelova J, Parsonage WA, Ashour Z, Shotan A, Oliver JM, Veldtman GR, Hall R, Roos-Hesselink JW.

Int J Cardiol. 2016 Oct 1;220:131-6. doi: 10.1016/j.ijcard.2016.06.061. Epub 2016 Jun 23. Erratum in: Int J Cardiol. 2017 Apr 1;232:348.

33.

Fellows' perspectives on training in adult congenital heart disease: Results of a survey from the International Society for Adult Congenital Heart Disease (ISACHD).

Bokma JP, Burchill LJ, Kovacs AH, Oechslin EN, Khairy P, Mulder BJ, Veldtman GR.

Int J Cardiol. 2016 Jan 1;202:253-5. doi: 10.1016/j.ijcard.2015.08.127. Epub 2015 Sep 14. No abstract available.

PMID:
26407046
34.

Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis.

Alsaied T, Alsidawi S, Allen CC, Faircloth J, Palumbo JS, Veldtman GR.

Heart. 2015 Nov;101(21):1731-7. doi: 10.1136/heartjnl-2015-307930. Epub 2015 Aug 28.

PMID:
26319122
35.

Contraception and cardiovascular disease.

Roos-Hesselink JW, Cornette J, Sliwa K, Pieper PG, Veldtman GR, Johnson MR.

Eur Heart J. 2015 Jul 14;36(27):1728-34, 1734a-1734b. doi: 10.1093/eurheartj/ehv141. Epub 2015 Apr 29. Review.

PMID:
25926560
36.

Overcoming the challenges of anticoagulation in adults with congenital heart disease.

Faircloth JM, Palumbo JS, Veldtman GR.

Heart. 2015 Mar;101(6):418-20. doi: 10.1136/heartjnl-2014-306805. Epub 2015 Jan 6. No abstract available.

PMID:
25564556
37.

Improved survival in Fontan-associated protein-losing enteropathy.

Veldtman GR, Webb GD.

J Am Coll Cardiol. 2014 Jul 8;64(1):63-5. doi: 10.1016/j.jacc.2014.05.002. No abstract available.

38.

Percutaneous closure of postinfarction ventricular septal defect: in-hospital outcomes and long-term follow-up of UK experience.

Calvert PA, Cockburn J, Wynne D, Ludman P, Rana BS, Northridge D, Mullen MJ, Malik I, Turner M, Khogali S, Veldtman GR, Been M, Butler R, Thomson J, Byrne J, MacCarthy P, Morrison L, Shapiro LM, Bridgewater B, de Giovanni J, Hildick-Smith D.

Circulation. 2014 Jun 10;129(23):2395-402. doi: 10.1161/CIRCULATIONAHA.113.005839. Epub 2014 Mar 25.

PMID:
24668286
39.

Therapeutic pulmonary artery stenting for metastatic bronchial carcinoid.

Vawdrey DB, Fitzsimmons S, Veldtman GR, Carpenter JP.

BMJ Case Rep. 2013 Sep 24;2013. pii: bcr2013201123. doi: 10.1136/bcr-2013-201123.

40.

Midterm evaluation of biological prosthetic valves in the pulmonary position of grown-up patients.

Vohra HA, Whistance RN, Baliulis G, Janusauskas V, Kaarne M, Veldtman GR, Roman K, Vettukattil JJ, Gnanapragasam J, Salmon AP, Haw MP.

Thorac Cardiovasc Surg. 2012 Apr;60(3):205-9. doi: 10.1055/s-0031-1295573. Epub 2012 Mar 12.

PMID:
22411751
41.

Permanent transvenous left ventricular endocardial pacing in a patient with univentricular atrioventricular connection.

Scott PA, Veldtman GR, Yue AM, Morgan JM.

Congenit Heart Dis. 2011 Sep-Oct;6(5):475-8. doi: 10.1111/j.1747-0803.2011.00517.x. Epub 2011 May 5.

PMID:
21545465
42.

Direct measurement of porto-systemic gradient in a failing Fontan circulation.

Velpula M, Sheron N, Guha N, Salmon T, Hacking N, Veldtman GR.

Congenit Heart Dis. 2011 Mar-Apr;6(2):175-8. doi: 10.1111/j.1747-0803.2010.00451.x. Epub 2011 Mar 1.

PMID:
21356034
43.

Catastrophic haemoptysis in the Fontan circulation--a novel surgical approach to denude the culprit bleeding vessels.

Black DE, Veldtman GR, Bryant T, Miller J, Haw M.

Cardiol Young. 2011 Aug;21(4):462-4. doi: 10.1017/S1047951111000163. Epub 2011 Feb 25.

PMID:
21349234
44.

Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions.

Bryant T, Ahmad Z, Millward-Sadler H, Burney K, Stedman B, Kendall T, Vettukattil J, Haw M, Salmon AP, Cope R, Hacking N, Breen D, Sheron N, Veldtman GR.

Int J Cardiol. 2011 Sep 15;151(3):268-72. doi: 10.1016/j.ijcard.2010.05.047. Epub 2010 Jun 16.

PMID:
20557964
45.
46.

Extraction of chronic pacing lead and angioplasty for complete superior baffle obstruction in complex congenital heart disease.

Sadagopan SN, Veldtman GR, Roberts PR.

Pacing Clin Electrophysiol. 2008 Dec;31(12):1661-3. doi: 10.1111/j.1540-8159.2008.01244.x.

PMID:
19067825
47.

A hybrid form of cardiac resynchronisation therapy in patients with failing systemic right ventricles.

Michael KA, Paisey JR, Mayosi BM, Robinson S, Allen S, Sunni NS, Roberts PR, Morgan JM, Veldtman GR.

J Interv Card Electrophysiol. 2008 Dec;23(3):229-33. doi: 10.1007/s10840-008-9296-0. Epub 2008 Oct 4.

PMID:
18836823
48.

Left ventricular dysfunction after cardiac resynchronization therapy in congenital heart disease patients with a failing systemic right ventricle.

Kiesewetter C, Michael K, Morgan J, Veldtman GR.

Pacing Clin Electrophysiol. 2008 Feb;31(2):159-62. doi: 10.1111/j.1540-8159.2007.00963.x.

PMID:
18233967
49.
50.

Sildenafil therapy in complex pulmonary atresia with pulmonary arterial hypertension.

Lim ZS, Vettukattill JJ, Salmon AP, Veldtman GR.

Int J Cardiol. 2008 Oct 13;129(3):339-43. Epub 2007 Nov 14.

PMID:
18006164

Supplemental Content

Loading ...
Support Center